Genetic variants in XRRC5 may predict development of venous thrombotic events in myeloma patients on thalidomide

Prerna Tewari; Elaine Kenny; Anthony Staines; Stephen Chanock; Paul Browne; Mark Lawler

doi:10.1182/blood-2009-03-211177

Genetic variants in XRRC5 may predict development of venous thrombotic events in myeloma patients on thalidomide

Prerna Tewari, Elaine Kenny, Anthony Staines, Stephen Chanock, Paul Browne, Mark Lawler

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	5691-5692
Number of pages	2
Journal	Blood
Volume	113
Issue number	22
DOIs	https://doi.org/10.1182/blood-2009-03-211177
State	Published - 2009
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2009-03-211177

Cite this

@article{d0fc03e13f9f4ff785ff661a8ee3ffb7,

title = "Genetic variants in XRRC5 may predict development of venous thrombotic events in myeloma patients on thalidomide",

author = "Prerna Tewari and Elaine Kenny and Anthony Staines and Stephen Chanock and Paul Browne and Mark Lawler",

year = "2009",

doi = "10.1182/blood-2009-03-211177",

language = "English (US)",

volume = "113",

pages = "5691--5692",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "22",

}

TY - JOUR

T1 - Genetic variants in XRRC5 may predict development of venous thrombotic events in myeloma patients on thalidomide

AU - Tewari, Prerna

AU - Kenny, Elaine

AU - Staines, Anthony

AU - Chanock, Stephen

AU - Browne, Paul

AU - Lawler, Mark

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=67049142872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67049142872&partnerID=8YFLogxK

U2 - 10.1182/blood-2009-03-211177

DO - 10.1182/blood-2009-03-211177

M3 - Letter

C2 - 19478055

AN - SCOPUS:67049142872

SN - 0006-4971

VL - 113

SP - 5691

EP - 5692

JO - Blood

JF - Blood

IS - 22

ER -

Genetic variants in XRRC5 may predict development of venous thrombotic events in myeloma patients on thalidomide

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this